Effects of chronic morphine pretreatment on the development of amygdaloid kindling, seizure suppression and benzodiazepine (BDZ) receptor binding in rats were evaluated. The morphine-pretreated animals showed faster acquisition of seizure activity. Further evaluation of the postictal seizure suppres
Effects of chronic naloxone pretreatment on amygdaloid kindling in rats
โ Scribed by Luisa Rocha; Jerome Engel Jr.; Robert F. Ackermann
- Publisher
- Elsevier Science
- Year
- 1991
- Tongue
- English
- Weight
- 649 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0920-1211
No coin nor oath required. For personal study only.
โฆ Synopsis
Effects of chronic naloxone pretreatment (75 or 270 micrograms/h for 14 days) on the development of amygdaloid kindling in rats were evaluated. The acquisition of seizure activity was modified in the naloxone pretreated animals, depending on the nucleus stimulated: facilitation of stages IV and V occurred in 37%, variability of electrographic and behavioral responses to electrical stimulation during the kindling development in 33%, and facilitation of stages IV and V followed by long periods of seizure suppression in 29%. Enhancement of postictal seizure suppression during a recycling paradigm was observed in all the naloxone pretreated rats. It was concluded that the chronic administration of naloxone (known to induce opioid binding upregulation and supersensitivity), in association with the enduring changes in opioid mechanisms provoked by kindled seizures, were responsible for the facilitation and suppression of epileptic activity. These findings support bidirectional modulatory effects of opioid peptides on epileptic seizures as well as the view that epileptic seizures can induce enduring alterations in opioid mechanisms.
๐ SIMILAR VOLUMES
The anticonvulsant properties of the endogenous excitatory amino acid antagonist, kynurenic acid (KYA), were studied in prepubescent and adult rats using the amygdaloid kindling model of epilepsy. Treatment with intracerebroventricular KYA (360 nmoles (adult dose) or 240 nmoles (prepuhescent dose))
One hundred-four Wistar rats were implanted with a bipolar electrode aimed at the right baso!ateral amygdala, and stimulated bipolarly twice daily (interval between stimulations 30 rain) with a 150 uA, 4-s train of biphasic square-wave l-ms pulses (100 pulses/s). Seventy-four animals developed a sti
The anticonvulsant effectiveness of AHR-11748 (3-[3-(trifluoromethyl)phenoxy]-1-azetidinecarboxamide) was evaluated in the kindled amygdaloid seizure model in rats. Doses of AHR-11748 that did not cause prestimulation toxicity significantly attenuated elicited afterdischarge durations and the severi